Recently shown to regulate cardiac development, the secreted axon guidance molecule
SLIT3
maintains its expression in the postnatal heart. Despite its known expression in the cardiovascular system after birth,
SLIT3
’s relevance to cardiovascular function in the postnatal state remains unknown. As such, the objectives of this study were to determine the postnatal myocardial sources of
SLIT3
and to evaluate its functional role in regulating the cardiac response to pressure overload stress. We first found that
SLIT3
transcription was increased in myocardial tissue obtained from patients with congenital heart defects that caused ventricular pressure overload. Immunostaining of hearts from wild type and reporter mice revealed that
SLIT3
is secreted by cardiac stromal cells, namely, fibroblasts and vascular mural cells, within the heart. Conditioned media from cardiac fibroblasts and vascular mural cells both stimulated cardiomyocyte hypertrophy in vitro, an effect that was partially inhibited by an anti-
SLIT3
antibody. Also, the N-terminal, but not the C-terminal, fragment of
SLIT3
and the forced overexpression of
SLIT3
stimulated cardiomyocyte hypertrophy and the transcription of hypertrophy-related genes. We next determined that
ROBO1
was the most highly expressed roundabout receptor in cardiomyocytes and that
ROBO1
mediated
SLIT3
’s hypertrophic effects in vitro. In vivo, Tcf21+ fibroblast and Tbx18+ vascular mural cell–specific knockout of
SLIT3
in mice resulted in decreased left ventricle hypertrophy and cardiac fibrosis after the transverse aortic constriction. Furthermore, α-MHC+ cardiomyocyte–specific deletion of
ROBO1
also preserved left ventricle function and abrogated hypertrophy, but not fibrosis, after the transverse aortic constriction. Collectively, these results indicate a novel role for the
SLIT3
-
ROBO1
signaling axis in regulating postnatal cardiomyocyte hypertrophy induced by pressure overload.